Study: Methods used to manage post-TAVR patients are safe

01/22/2013 | Healio

Warfarin plus a single antiplatelet drug or, if bleeding is an issue, warfarin alone were safe for patients following transcatheter aortic valve replacement, according to a study in the American Journal of Cardiology. "In general, we believe that patients who have indications for long-term anticoagulation should continue with this therapy irrespective of the TAVR procedure," the study's authors wrote.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Operations - GBS
Mayo Clinic
MN
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
SR REGULATORY AFFAIRS SPECIALIST - 14000005XI
Abbott
San Jose, CA
Director of Actuarial Services, Government Programs
PacificSource
OR